Immunicum’s abstract entitled “GMP production of an allogenic DC-based cancer vaccine (COMBIG-DC) for the treatment of patient with metastatic renal cancer using the ELUTRA ® Platform” is accepted for presentation at the Keystone Symposia on Molecular and Cellular Biology’s conference “Understanding Dendritic Cell Biology to Advance Disease Biology” in Keystone, Colorado, USA on March 3-8, 2013.
Authors: L Adamson; R Kiessling; B Näsman-Glaser; B Andersson; A Karlsson-Parra
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805